Wns (Holdings) Limited

◆英語タイトル:Wns (Holdings) Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3474
◆発行会社(調査会社):MarketLine
◆発行日:2019
◆ページ数:47
◆レポート言語:
◆レポート形式:PDF
◆納品方法:E
◆対象地域:
◆産業分野:Technology and Communications
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site LicenseUSD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide LicenseUSD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Wns (Holdings) Limited – Strategy, SWOT and Corporate Finance Report
Summary

Wns (Holdings) Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

WNS (Holdings) Ltd (WNS) is a business process management (BPM) company. The company offers data, voice, analytical, and business transformation services to various business enterprises.It delivers business process management services such as finance and accounting, customer interaction services, technology solutions, research and analytics, and industry specific back office and front office processes to clients. The company also provides end-to-end BPM solutions to a wide range of industries such astravel, banking, financial services, insurance, manufacturing, retail and consumer packaged goods, shipping and logistics, healthcare and utilities. The company conducts its business operations in North America, the UK, Australia, Europe, South Africa, and other locations. WNS is headquartered in Mumbai, Maharashtra, India.

Scope

- Detailed information on Wns (Holdings) Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Wns (Holdings) Limited in the form of a SWOT analysis
- An in-depth view of the business model of Wns (Holdings) Limited including a breakdown and examination of key business segments
- Intelligence on Wns (Holdings) Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Wns (Holdings) Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Wns (Holdings) Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Wns (Holdings) Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Wns (Holdings) Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
WNS (Holdings) Limited: Company Overview
WNS (Holdings) Limited: Overview and Key Facts
WNS (Holdings) Limited: Overview
WNS (Holdings) Limited: Key Facts
WNS (Holdings) Limited: Key Employees
WNS (Holdings) Limited: Key Employee Biographies
WNS (Holdings) Limited: Major Products and Services
WNS (Holdings) Limited: Company History
WNS (Holdings) Limited: Management Statement
WNS (Holdings) Limited: Locations and Subsidiaries
WNS (Holdings) Limited: Key Competitors
WNS (Holdings) Limited: Company Analysis
WNS (Holdings) Limited: Business Description
WNS (Holdings) Limited: SWOT Analysis
WNS (Holdings) Limited: SWOT Overview
WNS (Holdings) Limited: Strengths
WNS (Holdings) Limited: Weaknesses
WNS (Holdings) Limited: Opportunities
WNS (Holdings) Limited: Threats
WNS (Holdings) Limited: Corporate Financial Deals Activity
WNS (Holdings) Limited: Financial Deals Overview
WNS (Holdings) Limited: Targets and Partners
WNS (Holdings) Limited: Top Deals 2015 – 2019YTD*
WNS (Holdings) Limited: Mergers and Acquisitions
WNS (Holdings) Limited: Recent Developments
WNS (Holdings) Limited: News and Events Summary
WNS (Holdings) Limited: Business Expansion
WNS (Holdings) Limited: Contracts
WNS (Holdings) Limited: Corporate Governance
WNS (Holdings) Limited: Financial Deals
WNS (Holdings) Limited: Financial Performance
WNS (Holdings) Limited: Market Developments
WNS (Holdings) Limited: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: WNS (Holdings) Limited: Key Facts
Table 2: WNS (Holdings) Limited: Key Employees
Table 3: WNS (Holdings) Limited: Company History
Table 4: WNS (Holdings) Limited: Locations and Subsidiaries
Table 5: WNS (Holdings) Limited: Key Competitors
Table 6: WNS (Holdings) Limited: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: WNS (Holdings) Limited: M&A Average Deal Size - Value (US$m)
Table 8: WNS (Holdings) Limited: Targets and Partners
Table 9: WNS (Holdings) Limited: Top Deals 2015 - 2019YTD*
Table 10: WNS (Holdings) Limited: M&A Volume and Value Trend (2015 - YTD*2019)
Table 11: WNS (Holdings) Limited: M&A Activity by Geography (2015 - YTD*2019)
Table 12: WNS (Holdings) Limited: News and Events Summary
Table 13: WNS (Holdings) Limited: Business Expansion
Table 14: WNS (Holdings) Limited: Contracts
Table 15: WNS (Holdings) Limited: Corporate Governance
Table 16: WNS (Holdings) Limited: Financial Deals
Table 17: WNS (Holdings) Limited: Financial Performance
Table 18: WNS (Holdings) Limited: Market Developments
Table 19: WNS (Holdings) Limited: Strategy and Operations

★海外企業調査レポート[Wns (Holdings) Limited]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Corium International Inc (CORI):企業の製品パイプライン分析2018
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • Kesko Corporation:企業の戦略・SWOT・財務情報
    Kesko Corporation - Strategy, SWOT and Corporate Finance Report Summary Kesko Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Compagnie Financiere Richemont SA:戦略・SWOT・企業財務分析
    Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report Summary Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Student Transportation Inc.:企業の戦略・SWOT・財務分析
    Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report Summary Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • MakeMyTrip Limited:企業の戦略・SWOT・財務分析
    MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report Summary MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • UGI Corp (UGI):企業の財務・戦略的SWOT分析
    UGI Corp (UGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • First Abu Dhabi Bank (FAB):企業の財務・戦略的SWOT分析
    First Abu Dhabi Bank (FAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • The Siam Cement Public Co Ltd:企業の戦略・SWOT・財務分析
    The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Genting Malaysia Berhad:企業の戦略・SWOT・財務情報
    Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Otsuka Pharmaceutical Co., Ltd.:企業のM&A・事業提携・投資動向
    Otsuka Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Otsuka Pharmaceutical Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • DiaMedica Therapeutics Inc (DMA):企業の財務・戦略的SWOT分析
    Summary DiaMedica Therapeutics Inc (DiaMedica) formerly DiaMedica Inc, is a clinical-stage bio pharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 …
  • Abengoa, S.A.:企業の戦略・SWOT・財務情報
    Abengoa, S.A. - Strategy, SWOT and Corporate Finance Report Summary Abengoa, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Softship AG:企業の戦略的SWOT分析
    Softship AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • MannKind Corp (MNKD)-医療機器分野:企業M&A・提携分析
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type …
  • Nimbus Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Nimbus Therapeutics LLC (Nimbus Therapeutics), formerly Nimbus Discovery LLC, is a biotechnology company that develops medicines for critical diseases such as metabolic disease, cancer, and immune-inflammatory disorders. The company harnesses its expertise in deep computational chemistry to …
  • Aushon BioSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Aushon BioSystems Inc (Aushon) is a medical device provider that provides biomarker measurement and analysis products. The company offers biomarker therapeutic areas in microarray printing technology. It provides products such as ciraplex assay, cirascan imaging and cirasoft analysis and cir …
  • Orient Pharma Co Ltd (4166):製薬・医療:M&Aディール及び事業提携情報
    Summary Orient Pharma Co Ltd (Oripharm) is a pharmaceutical company that manufactures and distributes therapeutic drugs. The company develops drugs for anti-psychotics, Alzheimer’s disease, psychostimulants and Parkinson’s disease. Its drug delivery technologies include multi stages controlled techn …
  • TOT Public Company Limited:企業の戦略的SWOT分析
    TOT Public Company Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Arvinas Inc (ARVN):製薬・医療:M&Aディール及び事業提携情報
    Summary Arvinas Inc (Arvinas) is a biopharmaceutical company that develops protein degradation therapeutics. The company develops novel therapeutics for the treatment of pro-inflammatory, cancer, autoimmune and rare diseases. Its proprietary approach is to target disease causing proteins. Arvinas’s …
  • Rongsheng Petrochemical Co Ltd (002493):企業の財務・戦略的SWOT分析
    Summary Rongsheng Petrochemical Co Ltd (Rongsheng), a subsidiary of Zhejiang Rongsheng Holding Group Co Ltd is a chemical company that produces and distributes PTA, polyester fiber and chemical products. The company’s products include synthetic fibers and films, synthetic raw material, synthetic res …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆